The crystal structure of dipeptidyl peptidase IV(CD26) reveals its functional regulation and enzymatic mechanism

被引:279
作者
Engel, M
Hoffmann, T
Wagner, L
Wermann, M
Heiser, U
Kiefersauer, R
Huber, R
Bode, W
Demuth, HU
Brandstetter, H
机构
[1] Proteros Biostruct GmbH, D-82152 Martinsried, Germany
[2] Probiodrug AG, Biozentrum, D-06120 Halle An Der Saale, Germany
[3] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
关键词
serine protease; oxyanion hole; substrate channeling; drug design; diabetes mellitus;
D O I
10.1073/pnas.0230620100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The membrane-bound glycoprotein dipeptidyl peptidase IV (DP IV, CD26) is a unique multifunctional protein, acting as receptor, binding and proteolytic molecule. We have determined the sequence and 1.8 A crystal structure of native DP IV prepared from porcine kidney. The crystal structure reveals a 2-2-2 symmetric tetrameric assembly which depends on the natively glycosylated beta-propeller blade IV. The crystal structure indicates that tetramerization of DP IV is a key mechanism to regulate its interaction with other components. Each subunit comprises two structural domains, the N-terminal eight-bladed beta-propeller with open Velcro topology and the C-terminal alpha/beta-hydrolase domain. Analogy with the structurally related POP and tricorn protease suggests that substrates access the buried active site through the p-propeller tunnel while products leave the active site through a separate side exit. A dipeptide mimicking inhibitor complexed to the active site discloses key determinants for substrate recognition, including a Glu-Glu motif that distinguishes DIP IV as an aminopeptidase and an oxyanion trap that binds and activates the P-2-carbonyl oxygen necessary for efficient postproline cleavage. We discuss active and nonactive site-directed inhibition strategies of this pharmaceutical target protein.
引用
收藏
页码:5063 / 5068
页数:6
相关论文
共 58 条
[51]   ISOLATION AND CHARACTERIZATION OF DIPEPTIDYL PEPTIDASE-IV FROM HUMAN-PLACENTA [J].
PUSCHEL, G ;
MENTLEIN, R ;
HEYMANN, E .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 126 (02) :359-365
[52]   Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog [J].
Rasmussen, HB ;
Branner, S ;
Wiberg, FC ;
Wagtmann, N .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (01) :19-25
[53]   MOLECULAR-CLONING OF FIBROBLAST ACTIVATION PROTEIN-ALPHA, A MEMBER OF THE SERINE-PROTEASE FAMILY SELECTIVELY EXPRESSED IN STROMAL FIBROBLASTS OF EPITHELIAL CANCERS [J].
SCANLAN, MJ ;
RAJ, BKM ;
CALVO, B ;
GARINCHESA, P ;
SANZMONCASI, MP ;
HEALEY, JH ;
OLD, LJ ;
RETTIG, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5657-5661
[54]   CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity [J].
Schols, D ;
Proost, P ;
Struyf, S ;
Wuyts, A ;
De Meester, I ;
Scharpé, S ;
Van Damme, J ;
De Clercq, E .
ANTIVIRAL RESEARCH, 1998, 39 (03) :175-187
[55]   PEPTIDYL AMMONIUM METHYL KETONES AS SUBSTRATE-ANALOG INHIBITORS OF PROLINE-SPECIFIC PEPTIDASES [J].
STEINMETZER, T ;
SILBERRING, J ;
MRESTANIKLAUS, C ;
FITTKAU, S ;
BARTH, A ;
DEMUTH, HU .
JOURNAL OF ENZYME INHIBITION, 1993, 7 (02) :77-85
[56]   THE LOCKED ROTATION FUNCTION [J].
TONG, L ;
ROSSMANN, MG .
ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 :783-792
[57]   PROLINE-DEPENDENT STRUCTURAL AND BIOLOGICAL PROPERTIES OF PEPTIDES AND PROTEINS [J].
YARON, A ;
NAIDER, F .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1993, 28 (01) :31-81
[58]   Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic [J].
Zhao, K ;
Lim, DS ;
Funaki, T ;
Welch, JT .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (02) :207-215